NewsRx

Search our medical news database

TB Vaccines

Mycobacteria Evolved Mechanism to Elicit MHC Class I CTL

Published in TB and Outbreaks Week, November 11th, 1996

One of the great mysteries of tuberculosis infection is on the way to being solved.

At 2 million deaths per year, tuberculosis is the most lethal infectious disease. But the molecular basis for Mycobacterium tuberculosis (MTB) pathogenesis and for the mechanisms of protective immunity remain an enigma, thwarting efforts to develop an effective vaccine.

In 1992, J.L. Flynn and colleagues demonstrated that major histocompatibility complex (MHC) type I-restricted T-cells are required for mice to resist MTB infection (PNAS, 1992;89:2243-7).

But this clue itself raised a question: how can MTB, which after infecting a cell...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook